Stopped: Low accrual
This study is being done to identify markers that will allow researchers to identify in advance patients with sarcomas who are at highest risk for developing heart failure related to chemotherapy.
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
Changes in myocardial function - 2D-STE
Timeframe: Baseline, 3 months, 6 months, 1 year
Changes in myocardial function - 2D-STE vs 3D-STE
Timeframe: Baseline, 3 months, 6 months, 1 year
Changes in myocardial function - 2D-STE vs 2D-LVEF and 3D-LVEF
Timeframe: Baseline, 3 months, 6 months, 1 year
Changes in myocardial function - 2D-STE vs cardiac biomarkers
Timeframe: Baseline, 3 months, 6 months, 1 year